Retirement-related change in the Supervisory Board ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. professional career Norderstedt (euro adhoc) - Dr. Marc Sielemann (41) is assuming the position of COO Operations on Nordex AG´s Management Board effective April 1, 2009 and will be responsible for production, sourcing and service. Prior to this, he ...
Orlando, Florida (ots/PRNewswire) - Results from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C ...
Samsung Electronics (UK) & Europe Ltd
Vienna, Austria (ots/PRNewswire) - - Samsung Electronics Defines Company's European Strategy at First-Ever Samsung European Forum VIENNA, Austria, March 24 /PRNewswire/ -- A new era for Samsung Electronics Co. Ltd., begins in Europe today, with the launch of exciting new products and the announcement of new strategy for the European market. At the first ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. new product Unterföhring (euro adhoc) - Munich/London, 17 March 2009 - Brand Management company TV-Loonland is bringing a diverse slate of animated programming for all ages to this years MIP TV. ...
Sydney (ots/PRNewswire) - Fenofibrate treatment reduces cardiovascular disease (CVD) risk (defined by total cardiovascular events: the composite of cardiovascular death, myocardial infarction, stroke, and coronary and carotid revascularization) in patients with type 2 diabetes and atherogenic dyslipidemia, that ...
Collegeville, Pennsylvania (ots/PRNewswire) - The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), today adopted a positive opinion recommending to grant a marketing authorization for CONBRIZA(TM) (bazedoxifene) for the treatment ...
San Diego, California (ots/PRNewswire) - A new analysis from the JUPITER study presented today at the International Stroke Conference (ISC) in San Diego, California, describes details of the stroke data according to gender, ethnicity and baseline risk factors. This data adds to the primary analysis of the JUPITER study which demonstrated that CRESTOR® (rosuvastatin calcium) 20mg significantly reduced the risk of ...
New gonadotrophin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone Saint-Prex (ots) - Ferring Pharmaceuticals announced today that it has received marketing authorisation from the European Commission, for FIRMAGON® (degarelix), a new GnRH receptor antagonist ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.01.2009 ROSENBAUER International AG, the world market leader for special-purpose vehicles, yesterday signed a contract with the General Authority of Civil Aviation (GACA - the company ...
Beerse, Belgium (ots/PRNewswire) - - First and Only Biologic Approved With Infrequent, Every Twelve-Week Maintenance Dosing BEERSE, Belgium, January 22 /PRNewswire/ -- Janssen-Cilag announced today that STELARA(TM) (ustekinumab), the first in a new class of biologics, has been approved by the ...
Saint Prex, Switzerland (ots/PRNewswire) - - New Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist Demonstrates Rapid, Long-Term Suppression of Testosterone Ferring Pharmaceuticals received today notification that the Committee for Medicinal Products for Human Use (CHMP), part of the European ...
Basel, Switzerland (ots/PRNewswire) - - Roche Medicines Offer Improved Ways of Fighting the Leading Cause of Cancer Death in Women New data being presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin (trastuzumab), Avastin (bevacizumab) and oral Xeloda (capecitabine) ...
Basel, Switzerland (ots/PRNewswire) - - For Non-US and Non-UK Media Only - Abstract Number: 1 - New Phase III Data Suggest Potential Role for MabThera in Treating Blood Disorder New data presented at the 50th Annual Meeting of the American Society of Hematology (ASH) today, show that people living ...
Singapore, November 19 (ots/PRNewswire) - - Epic Fantasy From Director Robert Zemeckis and Starring Jim Carrey Leads Impressive Line-Up Disney's "A Christmas Carol," the spectacular 3D 2009 holiday release from director Robert Zemeckis and starring Jim Carrey, will be the first film from The Walt Disney Studios slated for IMAX(R) theatres under a new ...
New Orleans, November 11 (ots/PRNewswire) - - Baseline Data from RecordAF Presented at American Heart Association's Scientific Sessions Today Baseline data from the REgistry on Cardiac rhythm disORDers - an international, observational, prospective survey assessing the control of Atrial Fibrillation ...
Residual Risk Reduction Initiative (R3i)
New Orleans, Louisiana, November 7 (ots/PRNewswire) - - Residual Vascular Risk Reduction: The Global Call to Action - Announcement of the Launch of the Residual Risk Reduction Initiative: R3i KEY FACTS: Residual Risk Reduction Initiative (R3i) calls for action to reduce the lipid related residual vascular risk unaddressed by current standards of care ...
Ingelheim, Germany (ots/PRNewswire) - - 1 in 10 Women Experience Distress Associated With the Most Common Form of Female Sexual Dysfunction, yet the Condition Remains Largely Under-Recognised and Under-Diagnosed - For non-US media only Results from the PRESIDE*(1) survey, the largest study assessing the prevalence of female sexual problems, show that ...
Collegeville, Pennsylvania (ots/PRNewswire) - - Company Underscores Commitment to Availability in Worldwide Markets Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today provided an update on its global strategy for desvenlafaxine for the treatment of major depressive disorder (MDD) in adults. ...
London (ots/PRNewswire) - - World Contraception Day 2008 Highlights Scale and Impact of Unplanned Pregnancy Today, international sexual and reproductive health experts and successful recording artist and media personality Kelly Osbourne, call for more action to address the burgeoning problem of ...
Atrium European Real Estate Limited
- Senior management team strengthened with second appointment - ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. professional career St Helier Jersey / Channel Islands (euro adhoc) - 16 September 2008. Atrium European Real Estate (VSX: ATR), one ...
Paris (ots/PRNewswire) - - Abstracts 186 and 1003 Sanofi-aventis announced today that results from two studies, GINGER and LACE, presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) demonstrated that a basal-bolus insulin regimen with LANTUS(R) (insulin ...
Paris (ots/PRNewswire) - - Abstracts 185 and 1112 Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes (EASD) 44th Annual Meeting demonstrating that the "basal plus" insulin strategy ...
Rome (ots/PRNewswire) - - Exciting New Data From the FIELD Study Show Additional Microvascular-Associated Benefits of Fenofibrate - The First Time in a Large-Scale Prospective Study That any Lipid-Modifying Therapy has Been Shown to Significantly Reduce the Risk of Lower-Limb Amputation in Patients With Type 2 Diabetes Fenofibrate treatment in people ...
Cork, Ireland (ots/PRNewswire) - -INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 31.07.2008 GOETHE INVESTMENTS S. à r. l. has just informed the management board of ALTA FIDES Aktiengesellschaft für Grundvermögen that it acquired under the condition precedent of payment ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis. Aortic stenosis (which involves partial blockage of the aortic valve in the heart) is a relatively ...
Calgary, Canada (ots/PRNewswire) - - RVX-208 is the Only Apo-Al/HDL Drug to be Highlighted Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Resverlogix's lead drug is featured prominently in an article titled "Emerging Antidyslipidemic Drugs", which appears in the current edition of Expert Opinion of Emerging Drugs, a well respected scientific journal for the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 20.06.2008 Ad-hoc R E L E A S E o PALFINGER plans takeover of ELEVANT aerial working platforms unit from WUMAG GmbH Bergheim, Salzburg, 20 June 2008 PALFINGER AG, ...
The Schulich School of Business
Toronto, Ontario (ots/PRNewswire) - - Latest Evidence for Businesses to Justify Investing in Pandemic Preparedness Plans TORONTO, Ontario, June 17 /PRNewswire/ -- The Schulich School of Business today released the first study to assess the impact of an influenza pandemic on individual companies. Presented today at the World Conference on Disaster ...
Maidenhead, England (ots/PRNewswire) - - Study Results Provide Further Evidence That Early Treatment of Rheumatoid Arthritis With Enbrel(R) Plus Methotrexate in Moderate to Severe Patients can Stop the Disease From Progressing, and Helps Patients Return to More Normal and Productive Lives Data presented ...